Results 1 - 25 from 79 for "zentiva"
-
Production Expansion and Launch of New Products, Zentiva Romania’s Targets for Next 10 Years
11.27.2023
Zentiva Romania’s objectives for the next decade envisage expanding production at the two plants it owns in Bucharest and adding new products to its portfolio. more
-
Drugmaker Zentiva Sees Net Profit Quadruple To RON124M In Jan-Sep
11.15.2023
Drugmaker Zentiva (SCD) posted RON124 million net profit in the first nine months of 2023, compared with RON33.6 million in the same period last year, while revenue rose to RON684 million from RON538 more
-
Zentiva Turnover Up 24% YoY To RON450M In H1/2023
09.01.2023
Zentiva (SCD.RO), one of the largest pharmaceutical companies in Romania, had a turnover of RON450.6 million in the first six months of 2023, up 24% from the same period in 2022. more
-
Zentiva Sees Ninefold Increase In Q1 Profit To Over RON42M
05.16.2023
Pharmaceutical company Zentiva SA had a turnover of RON230 million in January-March 2023, up 36% on the year, and a profit of over RON42 million, almost nine times higher than RON5 million reported in more
-
Zentiva Group Appoints Zsolt Baranyai to Run Its Production Operations in Romania
04.06.2023
Zentiva Group, held by private equity firm Advent International, has put Zsolt Baranyai in charge of the production operations in Romania, replacing Margareta Tanase, who retired after working for more
-
Zentiva Seeks RON100M Profit and RON850M Sales in 2023
04.06.2023
Zentiva (SCD.RO), the largest pharmaceutical company listed on the Bucharest Stock Exchange, though with a low free float of merely 4%, is aiming for net sales of RON856 million and RON101.7 million more
-
Zentiva Appoints And Confirms Simona Cocos As Executive Board Chairwoman
03.22.2023
Zentiva (SCD.RO), one of the largest pharmaceuticals producers in Romania, on Wednesday (March 22) announced in a stock market report that the company’s Board of Directors decided the appointment more
-
Zentiva SA Ends 2022 with RON753M Turnover, Up 10%, RON89M Net Profit, Down 15% from 2021
03.01.2023
Pharmaceutical company in 2022 generated RON753 million turnover, up 10%, and RON89 million net profit, 15% lower than in 2021. more
-
Zentiva Turnover Up 7% YoY To RON538M In Jan-Sept 2022
11.16.2022
Pharmaceutical company Zentiva (SCD.RO), held by investment fund Advent International, registered a net turnover of RON538 million in the first nine months of 2022, up 7% on the year, as per the more
-
Zentiva Romania Ends 1H/2022 with RON362M Turnover, Up 10%, and RON31.7M Net Profit, Down 8% Vs 1H/2021
09.01.2022
Zentiva Romania, a major pharmaceutical manufacturer in Romania, in the first half of this year posted RON362 million turnover, up 10%, and net profit worth RON31.7 million, 8% lower than in the same more
-
Zentiva Posts RON169M Revenue in Q1
05.18.2022
Zentiva (SCD.RO) the largest pharmaceutical producer with facilities of its own in Romania, ended the first quarter of 2022 with growth of 7% in revenue to RON169.2 million, compared with the same more
-
Zentiva Invested EUR44M In Romania In Last 12 Years
05.10.2022
Zentiva Bucuresti, the medicine plant present in the local market for 60 years, has invested a total EUR44 million over the last 12 years in the production facility based in capital city Bucharest, more
-
Zentiva Plants In Romania Produced Over 162 Million Packs Of Medicines In 2021, 13% More YoY
04.05.2022
Zentiva Group, the main producer of generic medicines and the third largest pharmaceutical company in Romania, made 162 million packs of medicines in 2021 at its Zentiva and Labormed plants in capital more
-
Zentiva Turnover Up 17% To RON330M, Net Profit Down 17% To RON34M In 1H/2021
09.01.2021
Zentiva Romania (SCD.RO), one of the largest generics manufacturers in Romania, had a turnover of RON330 million in January-June 2021, up 17% on the year, and a net profit of RON34.5 million, down 17% more
-
Zentiva Romania 1Q Profit Drops 30%, to RON23.6M
05.17.2021
Zentiva Romania (SCD.RO), one of the largest generics manufacturers in Romania, reported a turnover of RON163 million for the first quarter of 2021, up 6.5% on the year, and a net profit of RON23.6 more
-
Zentiva Group Reports RON1.05B Sales in Romania in 2020
04.29.2021
Generics manufacturer Zentiva Group on Thursday reported sales of around RON1.05 billion in Romania in 2020, of which its factory in Bucharest generated RON558 million, 1% lower than in 2020, the more
-
Zentiva Climbs to Third Place Among Pharmaceutical Companies by Sales in Romania in 2020
03.04.2021
The strategy adopted at the onset of the pandemic to boost production capacity for drugs in demand drove local pharmaceutical manufacturer Zentiva to third place among the largest pharmaceutical more
-
Zentiva Net Profit Doubles YoY To RON41M In 1H/2020
08.21.2020
Pharmaceutical producer Zentiva Romania (SCD.RO) registered a turnover of RON281 million in the first half of 2020, close to the RON284.9 million level reported in the same period in 2019, per the more
-
Zentiva Romania Posts RON46.3M Profit in 2019
04.30.2020
Pharmaceutical producer Zentiva Romania (SCD.RO), 95.9% owned by Czech Zentiva Group, said Thursdy its turnover grew 16% in 2019, to RON535.4 million, and it made a profit of RON46.3 million. more
-
Zentiva Completes Acquisition of Alvogen's CEE Operations Including Romanian Labormed
04.07.2020
Zentiva Group, owned by Advent International, announced Tuesday it has completed the acquisition of Alvogen's Central and Eastern European (CEE) business. more
-
Zentiva Group Buys Alvogen’s Operations In CEE, Including Labormed Plant In Romania
10.25.2019
-
Zentiva Appoints New Provisional Director
10.01.2019
Pharmaceutical producer Zentiva (SCD.RO), owned by Czech Zentiva Group, said Tuesday it has appointed Kenneth Lynard as provisional director as of October 1, following the resignation of Blery Carol more
-
Zentiva Boosts Share Capital By RON28M To RON69.7M
09.09.2019
-
Zentiva 1H Net Profit Grows 36%, to RON49M
08.14.2019
Pharmaceutical producer Zentiva Romania (SCD.RO), 95.9% owned by Czech Zentiva Group, on Wednesday reported a net profit of RON48.9 million, up 36% on the year. more
-
Zentiva Gets Antitrust Clearance to Buy Solacium Brand from A&D Pharma
05.28.2019
Romania's antitrust body has cleared the deal whereby generics manufacturer Zentiva, owned by Advent International, took over the Romanian food supplement brand Solacium from A&D Pharma, owned by Dr. more